Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Obesity
100%
Benign Prostatic Hyperplasia
100%
Methylation
100%
Reductase
100%
Personalized Therapy
100%
Body Mass Index
50%
Protein Expression
50%
Prostate-specific Antigen
37%
Symptomatic Benign Prostatic Hyperplasia
37%
Increasing Age
25%
Prostate
25%
Prostate Volume
25%
Gene Promoter
25%
Methylation Status
25%
5α-reductase Inhibitors
25%
Gene Promoter Methylation
25%
Treatment Options
12%
Hypertension
12%
Diabetes
12%
Protein-coding Genes
12%
Predictive Models
12%
Gene Regulation
12%
Logistic Regression Modeling
12%
Therapeutic Effect
12%
Transurethral Resection of Prostate
12%
Clinical Variables
12%
Cardiac Risk
12%
Epigenetic Modification
12%
Epigenetic Signature
12%
Stepwise Logistic Regression
12%
Personalized Treatment
12%
Multivariate Statistical Analysis
12%
Univariate Statistical Analysis
12%
Obesity Regulation
12%
Medicine and Dentistry
Personalized Medicine
100%
Oxidoreductase
100%
Methylation
100%
Prostate Hypertrophy
100%
Body Mass Index
40%
Protein Expression
40%
Gene Promoter
40%
Prostate Specific Antigen
30%
Diabetes
10%
Logistic Regression Analysis
10%
Therapy Effect
10%
Transurethral Resection
10%
Hyperlipidemia
10%
Gene Control
10%
Epigenetic Modification
10%
Treatment Option
10%
Biochemistry, Genetics and Molecular Biology
Oxidoreductase
100%
Reductase
100%
Methylation
100%
Body Mass
40%
Protein Expression
40%
Gene Promoter
40%
Prostate-Specific Antigen
30%
Epigenetics
10%
Gene Control
10%
Multivariate Analysis
10%
Hyperlipidemia
10%
Epigenetic Modification
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Hypertrophy
100%
Oxidoreductase
100%
Prostate Specific Antigen
30%
Therapeutic Effect
10%
Hyperlipidemia
10%